How to Classify Medical Devices in India (Class A, B, C & D) – MDR 2017 Guide

Medical Device Classification in India

Class A, B, C & D — Practically Explained Under MDR 2017

By Ankur K. Khare – Biomedical Engineer | Regulatory Affairs Specialist | AI Ethics & Medical Innovation

---

Medical device classification in India is not paperwork.

It is the single decision that determines:

• Your regulatory pathway

• Your documentation burden

• Your clinical evidence requirements

• Your approval timelines

• Your compliance cost

Under the Medical Device Rules (MDR), 2017, every medical device is classified into Class A, B, C, or D based on risk.

Misclassify your device — and everything downstream becomes unstable.

This article explains classification practically, not just legally.

---

Why Classification Matters More Than You Think

Your classification affects:

• Whether you apply to State or Central authority

• Which forms you submit (MD-5, MD-9, MD-14, etc.)

• Whether clinical investigation is required

• How intense CDSCO scrutiny will be

• Post-market obligations

⚠️ Common Founder Mistake
Locking product design before confirming classification.

Classification must happen before engineering freezes.

---

Understanding the Risk-Based Framework

India follows a risk-based classification model, similar in principle to global regulatory systems.

The higher the risk to the patient, the higher the class.

Risk is evaluated based on:

• Invasiveness

• Duration of contact

• Whether it is implantable

• Whether it sustains life

• Whether it influences diagnosis or therapy

• Whether software drives critical decisions

---

Class A – Low Risk

Typical Examples:

• Surgical dressings

• Manual stethoscopes

• External, non-invasive instruments

Regulatory Features:

• Lower documentation burden

• Often self-certified with oversight

• Shorter approval timelines

Practical Insight:

Class A devices are low risk — but documentation discipline still matters.

🔍 Regulatory Reality
Even Class A applications get rejected when labeling or QMS documentation is weak.

---

Class B – Low to Moderate Risk

Typical Examples:

• Suction equipment

• Infusion pumps (in some contexts)

• Certain diagnostic devices

Regulatory Features:

• More detailed documentation

• Increased scrutiny

• Greater technical file expectations

Practical Insight:

Many startups assume their device is Class A — but it often falls into Class B.

Misclassification here causes delays.

---

Class C – Moderate to High Risk

Typical Examples:

• Ventilators

• Certain diagnostic imaging devices

• Implantable orthopedic devices

Regulatory Features:

• CDSCO involvement

• Strong technical file expectations

• Clinical evidence requirements

• Deep scrutiny of DMF

Practical Insight:

Class C is where timelines start expanding significantly.

You must plan for:

• Strong risk management

• Comprehensive validation

• Clear clinical justification

---

Class D – High Risk

Typical Examples:

• Cardiac stents

• Implantable pacemakers

• Life-sustaining critical devices

Regulatory Features:

• Highest regulatory scrutiny

• Mandatory clinical evidence

• Extensive documentation

• Ongoing surveillance obligations

Practical Insight:

For Class D, regulatory strategy becomes a central part of business strategy.

This is not a compliance exercise — it is a governance framework.

---

Software & AI Devices — Where Teams Get Confused

Under MDR 2017, software that:

• Drives diagnosis

• Influences therapy

• Controls hardware

• Interprets clinical data

May itself be classified as a medical device.

Risk classification depends on:

• Impact on patient outcome

• Level of autonomy

• Severity of decision influence

⚠️ Common Mistake
Assuming software is automatically low risk.

Incorrect classification in software devices is one of the fastest ways to trigger scrutiny.

---

How CDSCO Looks at Classification in Practice

CDSCO does not simply accept declared classification.

They assess:

• Intended use wording

• Claims in labeling

• Device functionality

• Clinical context

If claims suggest higher risk than declared class, scrutiny increases immediately.

🔍 Regulatory Reality
Classification inconsistencies between intended use and claims are a common rejection trigger.

---

A Practical Classification Strategy

Before finalizing classification:

✔ Lock intended use clearly
✔ Avoid marketing language
✔ Study official classification schedules
✔ Cross-check with global regulatory databases
✔ Document your classification rationale internally

Classification justification should be written — not assumed.

---

What Happens If You Misclassify?

Consequences include:

• Rejection or query issuance

• Requirement to refile

• Extended review cycles

• Increased compliance burden

• Credibility impact

Early correction is far cheaper than late rework.

---

A Simple Reality Check

Ask yourself:

▢ Have we locked intended use precisely?
▢ Does our claim language align with declared class?
▢ Have we documented classification reasoning?
▢ Have we checked if software components change risk class?

If not — pause before submission.

---

Final Thought

Medical device classification in India is not about labeling your product.

It is about understanding the risk your device introduces into the healthcare system.

Teams that approach classification strategically:

• Save months

• Reduce regulatory friction

• Build stronger documentation

• Move with confidence

Classification is the foundation.

Get it right — and everything else becomes manageable.

---

About the Author

Ankur Khare is a Biomedical Engineer and Regulatory Affairs Specialist working at the intersection of medical devices, AI, ethics, and Indian healthcare regulation.